Jari J. Lilja
- Pharmacology top 0.5%
- Oncology top 5%
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Surgery
- Co-authors
- Pertti J. NeuvonenKari T. KivistöJanne T. BackmanKari RaaskaMikko NeuvonenMikko NiemiJouko LaitilaHarri Luurila
- Topics
- Pharmacogenetics and Drug Metabolism (9 papers)Drug Transport and Resistance Mechanisms (8 papers)Pharmacological Effects and Toxicity Studies (6 papers)
- Cited by
- PharmacologyOncology
- Journals
- Clinical Pharmacology & TherapeuticsBritish Journal of Clinical PharmacologyEuropean Journal of Clinical Pharmacology
- Partner nations
- FinlandGermanyUnited States
In The Last Decade
Jari J. Lilja
20 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 92
- Pharmacology 668
- Oncology 575
- Pharmacology 301
- Pediatrics, Perinatology and Child Health 276
- Surgery 225
Countries citing papers authored by Jari J. Lilja
This map shows the geographic impact of Jari J. Lilja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jari J. Lilja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jari J. Lilja more than expected).
Fields of papers citing papers by Jari J. Lilja
This network shows the impact of papers produced by Jari J. Lilja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jari J. Lilja. The network helps show where Jari J. Lilja may publish in the future.
Co-authorship network of co-authors of Jari J. Lilja
This figure shows the co-authorship network connecting the top 25 collaborators of Jari J. Lilja. A scholar is included among the top collaborators of Jari J. Lilja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jari J. Lilja. Jari J. Lilja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 64 | |
| 2 | 62 | |
| 3 | 12 | |
| 4 | 57 | |
| 5 | 7 | |
| 6 | 35 | |
| 7 | 35 | |
| 8 | 78 | |
| 9 | 111 | |
| 10 | 16 | |
| 11 | 79 | |
| 12 | 107 | |
| 13 | 14 | |
| 14 | 73 | |
| 15 | 183 | |
| 16 | 53 | |
| 17 | 4 | |
| 18 | 44 | |
| 19 | 91 | |
| 20 | 239 |
About Jari J. Lilja
Jari J. Lilja is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Pharmacology (668 citations), Oncology (575 citations) and Pharmacology (301 citations). Jari J. Lilja has collaborated with scholars based in Finland, Germany and United States. Frequent co-authors include Pertti J. Neuvonen, Kari T. Kivistö, Janne T. Backman, Kari Raaska, Mikko Neuvonen, Mikko Niemi, Jouko Laitila, Harri Luurila, Kari T. Kivistö and Kalevi Laitinen. Their work appears in journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.